Kaposi's sarcoma herpesvirus microRNAs target caspase 3 and regulate apoptosis

PLoS Pathogens

Volumn 7, Issue 12, 2011, Pages

  Suffert, Guillaume ^a   Malterer, Georg ^b   Hausser, Jean ^c   Viiliäinen, Johanna ^d,i   Fender, Aurélie ^a   Contrant, Maud ^a   Ivacevic, Tomi ^e   Benes, Vladimir ^e   Gros, Frédéric ^a   Voinnet, Olivier ^f   Zavolan, Mihaela ^c   Ojala, Päivi M ^d,g,i   Haas, Juergen G ^b,h   Pfeffer, Sébastien ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^f INST DE BIOL MOLEC DES PLANTES   (France)

^g Foundation for the Finnish Cancer Institute   (Finland)

^h UNIVERSITY OF EDINBURGH   (United Kingdom)

ⁱ UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; LUCIFERASE; MICRORNA;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROTECTION; CELL STRAIN HEK293; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SITE DIRECTED MUTAGENESIS; WESTERN BLOTTING; BIOSYNTHESIS; CELL LINE; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; HERPES VIRUS INFECTION; METABOLISM; NICK END LABELING; NORTHERN BLOTTING; REAL TIME POLYMERASE CHAIN REACTION;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8;

APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CASPASE 3; CELL LINE; DOWN-REGULATION; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; IN SITU NICK-END LABELING; MICRORNAS; MUTAGENESIS, SITE-DIRECTED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84855274106     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002405     Document Type: Article

References (64)

1. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.
2. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
3. Ganem D, (2007) Kaposi's sarcoma-associated herpesvirus. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, editors. Fields Virology. 5th ed Philadelphia Lippincott, Williams & Wilkins pp. 2847-2888.
4. Mesri EA, Cesarman E, Boshoff C, (2010) Kaposi's sarcoma and its associated herpesvirus. Nat Rev Cancer 10: 707-719.
5. Moore PS, (2007) KSHV manipulation of the cell cycle and apoptosis. In: Arvin A, Campadelli-Fiume G, Mocarski ES, Moore PS, Roizman B, editors. Human herpesviruses Cambridge Cambridge University Press 2011/02/25 ed.
6. Ambros V, (2004) The functions of animal microRNAs. Nature 431: 350-355.
7. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
8. Kim VN, (2005) MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 6: 376-385.
9. Du T, Zamore PD, (2005) microPrimer: the biogenesis and function of microRNA. Development 132: 4645-4652.
10. Okamura K, Chung WJ, Lai EC, (2008) The long and short of inverted repeat genes in animals: microRNAs, mirtrons and hairpin RNAs. Cell Cycle 7: 2840-2845.
11. Meister G, Tuschl T, (2004) Mechanisms of gene silencing by double-stranded RNA. Nature 431: 343-349.
12. Eulalio A, Huntzinger E, Izaurralde E, (2008) Getting to the root of miRNA-mediated gene silencing. Cell 132: 9-14.
13. Pillai RS, Bhattacharyya SN, Filipowicz W, (2007) Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 17: 118-126.
14. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, et al. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773.
15. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
16. Orom UA, Nielsen FC, Lund AH, (2008) MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 30: 460-471.
17. Stern-Ginossar N, Elefant N, Zimmermann A, Wolf DG, Saleh N, et al. (2007) Host immune system gene targeting by a viral miRNA. Science 317: 376-381.
18. Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I, (2008) MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455: 1124-1128.
19. Skalsky RL, Cullen BR, (2010) Viruses, microRNAs, and host interactions. Annu Rev Microbiol 64: 123-141.
20. Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, et al. (2004) Identification of virus-encoded microRNAs. Science 304: 734-736.
21. Pfeffer S, (2008) Viral miRNAs: tiny but mighty helpers for large and small DNA viruses. Future Virol 3: 291-298.
22. Cai X, Lu S, Zhang Z, Gonzalez CM, Damania B, et al. (2005) Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci USA 102: 5570-5575.
23. Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, et al. (2005) Identification of microRNAs of the herpesvirus family. Nat Methods 2: 269-276.
24. Samols MA, Hu J, Skalsky RL, Renne R, (2005) Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus. J Virol 79: 9301-9305.
25. Grundhoff A, Sullivan CS, Ganem D, (2006) A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 12: 733-750.
26. Gottwein E, Mukherjee N, Sachse C, Frenzel C, Majoros WH, et al. (2007) A viral microRNA functions as an orthologue of cellular miR-155. Nature 450: 1096-1099.
27. Skalsky RL, Samols MA, Plaisance KB, Boss IW, Riva A, et al. (2007) Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol 81: 12836-12845.
28. Hengartner MO, (2000) The biochemistry of apoptosis. Nature 407: 770-776.
29. Kedes DH, Ganem D, (1997) Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy. J Clin Invest 99: 2082-2086.
30. Arvanitakis L, Mesri EA, Nador RG, Said JW, Asch AS, et al. (1996) Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood 88: 2648-2654.
31. Segal-Bendirdjian E, Jacquemin-Sablon A, (1995) Cisplatin resistance in a murine leukemia cell line is associated with a defective apoptotic process. Exp Cell Res 218: 201-212.
32. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, et al. (1994) Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84: 1415-1420.
33. Gabay C, Ben-Bassat H, Schlesinger M, Laskov R, (1999) Somatic mutations and intraclonal variations in the rearranged Vkappa genes of B-non-Hodgkin's lymphoma cell lines. Eur J Haematol 63: 180-191.
34. Ben-Bassat H, Goldblum N, Mitrani S, Goldblum T, Yoffey JM, et al. (1977) Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75). Int J Cancer 19: 27-33.
35. Dölken L, Malterer G, Erhard F, Kothe S, Friedel CC, et al. (2010) Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe 7: 324-334.
36. Sun Y, Orrenius S, Pervaiz S, Fadeel B, (2005) Plasma membrane sequestration of apoptotic protease-activating factor-1 in human B-lymphoma cells: a novel mechanism of chemoresistance. Blood 105: 4070-4077.
37. Edgell CJ, McDonald CC, Graham JB, (1983) Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA 80: 3734-3737.
38. Lin YT, Kincaid RP, Arasappan D, Dowd SE, Hunicke-Smith SP, et al. (2010) Small RNA profiling reveals antisense transcription throughout the KSHV genome and novel small RNAs. RNA 16: 1540-1558.
39. Samols MA, Skalsky RL, Maldonado AM, Riva A, Lopez MC, et al. (2007) Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog 3: e65.
40. Vieira J, O'Hearn PM, (2004) Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Virology 325: 225-240.
41. Meister G, Landthaler M, Dorsett Y, Tuschl T, (2004) Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 10: 544-550.
42. Obad S, dos Santos CO, Petri A, Heidenblad M, Broom O, et al. (2011) Silencing of microRNA families by seed-targeting tiny LNAs. Nat Genet 43: 371-378.
43. Wang HW, Trotter MW, Lagos D, Bourboulia D, Henderson S, et al. (2004) Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 36: 687-693.
44. Ziegelbauer JM, Sullivan CS, Ganem D, (2009) Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs. Nat Genet 41: 130-134.
45. Lei X, Bai Z, Ye F, Xie J, Kim CG, et al. (2010) Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat Cell Biol 12: 193-199.
46. Gottwein E, Cullen BR, (2010) A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest. J Virol 84: 5229-5237.
47. Abend JR, Uldrick T, Ziegelbauer JM, (2010) Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression. J Virol 84: 12139-12151.
48. Henry-Mowatt J, Dive C, Martinou JC, James D, (2004) Role of mitochondrial membrane permeabilization in apoptosis and cancer. Oncogene 23: 2850-2860.
49. Riedl SJ, Salvesen GS, (2007) The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 8: 405-413.
50. Ashkenazi A, (2002) Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer 2: 420-430.
51. Rowinsky EK, (2005) Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents. J Clin Oncol 23: 9394-9407.
52. Debatin KM, Krammer PH, (2004) Death receptors in chemotherapy and cancer. Oncogene 23: 2950-2966.
53. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, et al. (1995) A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 270: 7795-7798.
54. Chen M, Wang J, (2002) Initiator caspases in apoptosis signaling pathways. Apoptosis 7: 313-319.
55. Walsh JG, Cullen SP, Sheridan C, Luthi AU, Gerner C, et al. (2008) Executioner caspase-3 and caspase-7 are functionally distinct proteases. Proc Natl Acad Sci USA 105: 12815-12819.
56. Modesti M, Budzowska M, Baldeyron C, Demmers JA, Ghirlando R, et al. (2007) RAD51AP1 is a structure-specific DNA binding protein that stimulates joint molecule formation during RAD51-mediated homologous recombination. Mol Cell 28: 468-481.
57. Koopal S, Furuhjelm JH, Jarviluoma A, Jaamaa S, Pyakurel P, et al. (2007) Viral oncogene-induced DNA damage response is activated in Kaposi sarcoma tumorigenesis. PLoS Pathog 3: 1348-1360.
58. Wang L, Damania B, (2008) Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells. Cancer Res 68: 4640-4648.
59. Ramos da Silva S, Bacchi MM, Bacchi CE, Elgui de Oliveira D, (2007) Human bcl-2 expression, cleaved caspase-3, and KSHV LANA-1 in Kaposi sarcoma lesions. Am J Clin Pathol 128: 794-802.
60. Zhou FC, Zhang YJ, Deng JH, Wang XP, Pan HY, et al. (2002) Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis. J Virol 76: 6185-6196.
61. Dieker J, Cisterna B, Monneaux F, Decossas M, van der Vlag J, et al. (2008) Apoptosis-linked changes in the phosphorylation status and subcellular localization of the spliceosomal autoantigen U1-70K. Cell Death Differ 15: 793-804.
62. Dölken L, Perot J, Cognat V, Alioua A, John M, et al. (2007) Mouse cytomegalovirus microRNAs dominate the cellular small RNA profile during lytic infection and show features of posttranscriptional regulation. J Virol 81: 13771-13782.
63. Pfeffer S, (2007) Identification of Virally Encoded MicroRNAs. Methods Enzymol 427: 51-63.
64. Shi R, Chiang VL, (2005) Facile means for quantifying microRNAs expression by real-time PCR. BioTechniques 39: 519-525.